Nikos G. Gavalas

1.1k total citations
21 papers, 772 citations indexed

About

Nikos G. Gavalas is a scholar working on Molecular Biology, Immunology and Cell Biology. According to data from OpenAlex, Nikos G. Gavalas has authored 21 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Immunology and 5 papers in Cell Biology. Recurrent topics in Nikos G. Gavalas's work include melanin and skin pigmentation (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Nikos G. Gavalas is often cited by papers focused on melanin and skin pigmentation (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Nikos G. Gavalas collaborates with scholars based in Greece, United Kingdom and United States. Nikos G. Gavalas's co-authors include E. Helen Kemp, Anthony P. Weetman, Meletios Α. Dimopoulos, Philip F. Watson, David J. Gawkrodger, Aristotle Bamias, Katerina E. Tsitsanou, Nikos G. Oikonomakos, L.N. Johnson and V.T. Skamnaki and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Biochemical and Biophysical Research Communications.

In The Last Decade

Nikos G. Gavalas

19 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nikos G. Gavalas Greece 14 293 199 156 154 89 21 772
Sangeetha Palakurthi United States 11 654 2.2× 162 0.8× 65 0.4× 278 1.8× 52 0.6× 22 931
Karolina Sterzyńska Poland 18 428 1.5× 101 0.5× 68 0.4× 325 2.1× 90 1.0× 36 811
Weiguo Huang China 20 605 2.1× 122 0.6× 177 1.1× 181 1.2× 37 0.4× 51 1.1k
Elena Cavadini Italy 19 669 2.3× 103 0.5× 71 0.5× 160 1.0× 27 0.3× 30 877
Pingping Lou United States 11 323 1.1× 99 0.5× 26 0.2× 323 2.1× 19 0.2× 18 751
Fiona Furlong Ireland 18 887 3.0× 170 0.9× 130 0.8× 326 2.1× 43 0.5× 34 1.3k
Mary M. Vaughan United States 17 497 1.7× 52 0.3× 157 1.0× 370 2.4× 22 0.2× 27 1.0k
Yuanjie Niu China 21 729 2.5× 102 0.5× 93 0.6× 306 2.0× 34 0.4× 41 1.4k
Sanchita Rauth United States 18 558 1.9× 171 0.9× 62 0.4× 378 2.5× 26 0.3× 36 962

Countries citing papers authored by Nikos G. Gavalas

Since Specialization
Citations

This map shows the geographic impact of Nikos G. Gavalas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikos G. Gavalas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikos G. Gavalas more than expected).

Fields of papers citing papers by Nikos G. Gavalas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikos G. Gavalas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikos G. Gavalas. The network helps show where Nikos G. Gavalas may publish in the future.

Co-authorship network of co-authors of Nikos G. Gavalas

This figure shows the co-authorship network connecting the top 25 collaborators of Nikos G. Gavalas. A scholar is included among the top collaborators of Nikos G. Gavalas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikos G. Gavalas. Nikos G. Gavalas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bamias, Aristotelis, Nikos G. Gavalas, Kimon Tzannis, et al.. (2025). Intravesical Administration of Durvalumab for High-risk Non–muscle-invasive Bladder Cancer: A Phase 2 Study by the Hellenic GU Cancer Group. European Urology. 87(3). 281–284.
2.
Konstantaki, Maria, et al.. (2022). Optical fiber sensors in agricultural applications. 3 indexed citations
3.
Stefanou, Dimitra, Aristotelis Bamias, Soterios Α. Kyrtopoulos, et al.. (2021). Correction: Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer. PLoS ONE. 16(8). e0256051–e0256051. 1 indexed citations
4.
Gavalas, Nikos G., et al.. (2018). Physicochemical Properties of Magnetic Nanoparticles: Implications for Biomedical Applications In Vitro and In Vivo. Oncology Research and Treatment. 41(3). 139–143. 37 indexed citations
5.
Pilalis, Eleftherios, Nikos G. Gavalas, Kimon Tzannis, et al.. (2016). The Development of an Angiogenic Protein “Signature” in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling. PLoS ONE. 11(6). e0156403–e0156403. 21 indexed citations
6.
Stefanou, Dimitra, Aristotelis Bamias, Soterios Α. Kyrtopoulos, et al.. (2015). Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer. PLoS ONE. 10(2). e0117654–e0117654. 31 indexed citations
7.
Gavalas, Nikos G.. (2014). Angio-Inhibitors in Ovarian Cancer. Journal of Cancer Science & Therapy. 6(11).
8.
Gavalas, Nikos G., Michalis Liontos, Tina Bagratuni, et al.. (2013). Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer. International Journal of Molecular Sciences. 14(8). 15885–15909. 107 indexed citations
9.
Ziogas, Apostolos C, Nikos G. Gavalas, Marinos Tsiatas, et al.. (2011). VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2. International Journal of Cancer. 130(4). 857–864. 129 indexed citations
10.
Gavalas, Nikos G., Alexandra Karadimou, Meletios Α. Dimopoulos, & Aristotelis Bamias. (2010). Immune Response in Ovarian Cancer: How Is the Immune SystemInvolved in Prognosis and Therapy: Potential for Treatment Utilization. Journal of Immunology Research. 2010(1). 791603–791603. 45 indexed citations
11.
Gavalas, Nikos G., Raju V.S.R.K. Gottumukkala, David J. Gawkrodger, et al.. (2009). Mapping of melanin‐concentrating hormone receptor 1 B cell epitopes predicts two major binding sites for vitiligo patient autoantibodies. Experimental Dermatology. 18(5). 454–463. 12 indexed citations
12.
Tzanela, Marinella, et al.. (2009). The effect of body mass index on the diagnosis of GH deficiency in patients at risk due to a pituitary insult. European Journal of Endocrinology. 162(1). 29–35. 7 indexed citations
13.
Kemp, E. Helen, Nikos G. Gavalas, Kai Krohn, et al.. (2009). Activating Autoantibodies against the Calcium-Sensing Receptor Detected in Two Patients with Autoimmune Polyendocrine Syndrome Type 1. The Journal of Clinical Endocrinology & Metabolism. 94(12). 4749–4756. 43 indexed citations
14.
Gavalas, Nikos G., Meletios Α. Dimopoulos, & Aristotelis Bamias. (2009). Anti-tumor immune response in ovarian cancer: clinical implications, prognostic significance and potential for novel treatment strategies. Oncology Reviews. 3(3). 173–186. 1 indexed citations
15.
Gavalas, Nikos G., E. Helen Kemp, Kai Krohn, et al.. (2007). The Calcium-Sensing Receptor Is a Target of Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1. The Journal of Clinical Endocrinology & Metabolism. 92(6). 2107–2114. 58 indexed citations
16.
Gavalas, Nikos G., Samia Akhtar, David J. Gawkrodger, et al.. (2006). Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo. Biochemical and Biophysical Research Communications. 345(4). 1586–1591. 59 indexed citations
17.
Kemp, E. Helen, Nikos G. Gavalas, David J. Gawkrodger, & Anthony P. Weetman. (2006). Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo. Autoimmunity Reviews. 6(3). 138–142. 67 indexed citations
18.
Gottumukkala, Raju V.S.R.K., Nikos G. Gavalas, Samia Akhtar, et al.. (2006). Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients. Laboratory Investigation. 86(8). 781–789. 18 indexed citations
19.
Akhtar, Samia, Nikos G. Gavalas, David J. Gawkrodger, et al.. (2005). An insertion/deletion polymorphism in the gene encoding angiotensin converting enzyme is not associated with generalised vitiligo in an English population. Archives of Dermatological Research. 297(2). 94–98. 18 indexed citations
20.
Oikonomakos, Nikos G., V.T. Skamnaki, Katerina E. Tsitsanou, Nikos G. Gavalas, & L.N. Johnson. (2000). A new allosteric site in glycogen phosphorylase b as a target for drug interactions. Structure. 8(6). 575–584. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026